| Nicholas Patrick Ferro, DPM | |
|
2818 Grant Line Rd, New Albany, IN 47150-2492 | |
| (812) 725-7542 | |
| (812) 725-7543 |
| Full Name | Nicholas Patrick Ferro |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 15 Years |
| Location | 2818 Grant Line Rd, New Albany, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699906818 | NPI | - | NPPES |
| 7100205380 | Medicaid | KY | |
| 201071090 | Medicaid | IN | |
| 50041802 | Other | KY | PASSPORT HEALTH PLAN |
| 000000773843 | Other | IN | ANTHEM |
| Facility Name | Location | Facility Type |
|---|---|---|
| Physicians' Medical Center Llc | New albany, IN | Hospital |
| Clark Memorial Hospital | Jeffersonville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentuckiana Foot And Ankle Pllc | 4880752443 | 22 |
| Kentuckiana Foot And Ankle Pllc | 4880752443 | 22 |
News Archive
New research from the University of Sussex shows that taking part in Dry January - abstaining from booze for a month - sees people regaining control of their drinking, having more energy, better skin and losing weight. They also report drinking less months later.
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
Understanding what drives food choices can help high-volume food service operations like universities reduce waste, according to a new study.
Micromet, Inc. today announced that its licensee for MT111, MedImmune, plans to initiate a Phase 1 trial in patients with advanced gastrointestinal cancers based on an investigational new drug (IND) application recently accepted by the U.S. Food and Drug Administration (FDA).
› Verified 4 days ago
| Provider Name | Kentuckiana Foot & Ankle Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114177979 PECOS PAC ID: 4880752443 Enrollment ID: O20081027000074 |
News Archive
New research from the University of Sussex shows that taking part in Dry January - abstaining from booze for a month - sees people regaining control of their drinking, having more energy, better skin and losing weight. They also report drinking less months later.
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
Understanding what drives food choices can help high-volume food service operations like universities reduce waste, according to a new study.
Micromet, Inc. today announced that its licensee for MT111, MedImmune, plans to initiate a Phase 1 trial in patients with advanced gastrointestinal cancers based on an investigational new drug (IND) application recently accepted by the U.S. Food and Drug Administration (FDA).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Patrick Ferro, DPM 4612 Outer Loop, Louisville, KY 40219-3971 Ph: (502) 804-4811 | Nicholas Patrick Ferro, DPM 2818 Grant Line Rd, New Albany, IN 47150-2492 Ph: (812) 725-7542 |
News Archive
New research from the University of Sussex shows that taking part in Dry January - abstaining from booze for a month - sees people regaining control of their drinking, having more energy, better skin and losing weight. They also report drinking less months later.
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
Understanding what drives food choices can help high-volume food service operations like universities reduce waste, according to a new study.
Micromet, Inc. today announced that its licensee for MT111, MedImmune, plans to initiate a Phase 1 trial in patients with advanced gastrointestinal cancers based on an investigational new drug (IND) application recently accepted by the U.S. Food and Drug Administration (FDA).
› Verified 4 days ago
Ansert Foot & Ankle Center P.s.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 2315 Green Valley Rd, Ste 200, New Albany, IN 47150 Phone: 812-949-1002 Fax: 812-949-1007 | |
Dr. Steven R. Mosley, D. P. M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5120 Charlestown Rd, Ste 6, New Albany, IN 47150 Phone: 812-944-5600 Fax: 812-944-4674 | |
David Henry Bolonkin, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2818 Grant Line Rd, New Albany, IN 47150 Phone: 812-725-7542 Fax: 812-725-7543 | |
Dr. T Joseph D Spires, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1919 State St, Suite 104, New Albany, IN 47150 Phone: 812-944-2663 Fax: 812-981-7285 | |
Dr. Zahid Amirali Ladha, DPM.,F.A.C.F.A.S. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3605 Northgate Ct, Suite 206, New Albany, IN 47150 Phone: 812-945-9221 Fax: 812-945-7141 | |
Dr. Donald R Ansert Jr., D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2315 Green Valley Rd, Ste. 200, New Albany, IN 47150 Phone: 812-949-1002 Fax: 812-949-1007 | |
Foot & Ankle Specialists Podiatrist Medicare: Medicare Enrolled Practice Location: 2857 Charlestown Rd Ste 300, New Albany, IN 47150 Phone: 812-948-0211 Fax: 812-948-0880 |